Re:AstraZeneca vaccine doesn't prevent B1351 Covid in early ...
by 360walk on Wednesday March 17, 2021 @06:58AM
(#26489266)
Regarding the question about how the vaccine could protect against severe but not mild infection, I think they answer that here:
> Antibodies can prevent infection, your T cell-responses ensure that those antibodies keep doing their job and they kick in after you're infected OR oh my goodness stop the presses- VACCINATED (how about them apples). In other words, while robust T-cells responses cannot protect you from a mild or moderate infection sometimes (think cough, sniffles, etc.) they can however proliferate rapidly and prevent the build up of viral load. Psst- you want this to be LOW. VL drives disease severity.
The study in the article didn’t look at antibody response, but at the clinical outcome - just like the original Phase III studies did, just with a smaller group of people.
As for the claim that we don’t know how the vaccine protects from hospitalisations - if there is literally no difference in mild cases, why would there be any difference in severe?
Is there a single vaccine for any disease that offers no protection against mild cases, but a high protection from severe?